Literature DB >> 16362810

Post-epidemic serosurvey of West Nile fever in Israel.

M Y Chowers1, M S Green, H Bin, M Weinberger, F Schlaeffer, S Pitlik, J Bishara, Z Kaufman, R Dichtiar, E Mendelson, S Segev.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2005        PMID： 16362810     DOI： 10.1007/s10096-005-0061-3

Source DB:  PubMed          Journal:  Eur J Clin Microbiol Infect Dis        ISSN： 0934-9723            Impact factor:   3.267


× No keyword cloud information.
  9 in total

1.  Prevalence of antibodies to West Nile fever, sandfly fever Sicilian, and sandfly fever Naples viruses in healthy adults in Israel.

Authors:  D Cohen; Y Zaide; E Karasenty; M Schwarz; J W LeDuc; R Slepon; T G Ksiazek; J Shemer; M S Green
Journal:  Public Health Rev       Date:  1999

2.  [The isolation of the west nile virus in Israel].

Authors:  H BERNKOPF
Journal:  Harefuah       Date:  1953-09-01

3.  West Nile fever; the clinical features of the disease and the isolation of West Nile virus from the blood of nine human cases.

Authors:  N GOLDBLUM; V V STERK; B PADERSKI
Journal:  Am J Hyg       Date:  1954-01

Review 4.  West Nile fever in Israel 1999-2000: from geese to humans.

Authors:  H Bin; Z Grossman; S Pokamunski; M Malkinson; L Weiss; P Duvdevani; C Banet; Y Weisman; E Annis; D Gandaku; V Yahalom; M Hindyieh; L Shulman; E Mendelson
Journal:  Ann N Y Acad Sci       Date:  2001-12       Impact factor: 5.691

5.  West Nile encephalitis epidemic in southeastern Romania.

Authors:  T F Tsai; F Popovici; C Cernescu; G L Campbell; N I Nedelcu
Journal:  Lancet       Date:  1998-09-05       Impact factor: 79.321

6.  Epidemic West Nile encephalitis, New York, 1999: results of a household-based seroepidemiological survey.

Authors:  F Mostashari; M L Bunning; P T Kitsutani; D A Singer; D Nash; M J Cooper; N Katz; K A Liljebjelke; B J Biggerstaff; A D Fine; M C Layton; S M Mullin; A J Johnson; D A Martin; E B Hayes; G L Campbell
Journal:  Lancet       Date:  2001-07-28       Impact factor: 79.321

7.  Community-based prevalence profile of arboviral, rickettsial, and Hantaan-like viral antibody in the Nile River Delta of Egypt.

Authors:  A Corwin; M Habib; D Watts; M Darwish; J Olson; B Botros; R Hibbs; M Kleinosky; H W Lee; R Shope
Journal:  Am J Trop Med Hyg       Date:  1993-06       Impact factor: 2.345

8.  Seroprevalence of West Nile, Rift Valley, and sandfly arboviruses in Hashimiah, Jordan.

Authors:  A Batieha; E K Saliba; R Graham; E Mohareb; Y Hijazi; P Wijeyaratne
Journal:  Emerg Infect Dis       Date:  2000 Jul-Aug       Impact factor: 6.883

9.  West Nile fever outbreak, Israel, 2000: epidemiologic aspects.

Authors:  M Weinberger; S D Pitlik; D Gandacu; R Lang; F Nassar; D Ben David; E Rubinstein; A Izthaki; J Mishal; R Kitzes; Y Siegman-Igra; M Giladi; N Pick; E Mendelson; H Bin; T Shohat
Journal:  Emerg Infect Dis       Date:  2001 Jul-Aug       Impact factor: 6.883
  9 in total
  5 in total

1.  Chimeric vaccine composed of viral peptide and mammalian heat-shock protein 60 peptide protects against West Nile virus challenge.

Authors:  Orly Gershoni-Yahalom; Shimon Landes; Smadar Kleiman-Shoval; David Ben-Nathan; Michal Kam; Bat-El Lachmi; Yevgeny Khinich; Michael Simanov; Itzhak Samina; Anat Eitan; Irun R Cohen; Bracha Rager-Zisman; Angel Porgador
Journal:  Immunology       Date:  2010-03-16       Impact factor: 7.397

2.  Spatial and temporal distribution of West Nile virus in horses in Israel (1997-2013)--from endemic to epidemics.

Authors:  Karin Aharonson-Raz; Anat Lichter-Peled; Shlomit Tal; Boris Gelman; Daniel Cohen; Eyal Klement; Amir Steinman
Journal:  PLoS One       Date:  2014-11-17       Impact factor: 3.240

3.  The seroprevalence of West Nile Virus in Israel: A nationwide cross sectional study.

Authors:  Ravit Bassal; Tamy Shohat; Zalman Kaufman; Batya Mannasse; Eilat Shinar; Doron Amichay; Mira Barak; Anat Ben-Dor; Adina Bar Haim; Daniel Cohen; Ella Mendelson; Yaniv Lustig
Journal:  PLoS One       Date:  2017-06-16       Impact factor: 3.240

4.  Population seroprevalence study after a West Nile virus lineage 2 epidemic, Greece, 2010.

Authors:  Georgia A F Ladbury; Magda Gavana; Kostas Danis; Anna Papa; Dimitris Papamichail; Spiros Mourelatos; Sandra Gewehr; George Theocharopoulos; Stefanos Bonovas; Alexis Benos; Takis Panagiotopoulos
Journal:  PLoS One       Date:  2013-11-18       Impact factor: 3.240

5.  West Nile Virus Seroprevalence in the Greek Population in 2013: A Nationwide Cross-Sectional Survey.

Authors:  Christos Hadjichristodoulou; Spyros Pournaras; Maria Mavrouli; Andriani Marka; Persefoni Tserkezou; Agoritsa Baka; Charalambos Billinis; Antonios Katsioulis; Anna Psaroulaki; Anna Papa; Nikos Papadopoulos; Zissis Mamuris; Athanasios Tsakris; Jenny Kremastinou
Journal:  PLoS One       Date:  2015-11-25       Impact factor: 3.240
  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.